Page 1 of Clinical Trials for transplant related mortality, 448 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
GVH 0313: Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies at High Risk for Transplant Related Mortality With Standard Transplantation
Last Updated: June 29, 2009
Condition(s): Graft vs Host Disease
2
Terminated
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Last Updated: January 4, 2011
Condition(s): Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
3
Completed
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
Last Updated: September 16, 2011
Condition(s): Acute Leukaemia; Chronic Disease; Leukemia; Myelodysplasia; Lymphoma
4
Suspended
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor
Last Updated: April 11, 2012
Condition(s): Myeloid Leukemia; Lymphoblastic Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome; Myeloproliferative Disorders
5
Terminated
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
Last Updated: March 19, 2012
Condition(s): Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
6
Suspended
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Last Updated: April 1, 2011
Condition(s): Lymphoma; Leukemia; Multiple Myeloma; Myelodysplastic Syndrome
7
Terminated
Non-Myeloablative HLA-Matched Ex-Vivo T-Cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Last Updated: December 28, 2007
Condition(s): Lymphoma; Leukemia; Multiple Myeloma; Myelodysplastic Syndrome
8
Recruiting
Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Last Updated: April 4, 2012
Condition(s): Hematologic Malignancy
9
Recruiting
Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior AlloHSCT in AML
Last Updated: June 27, 2011
Condition(s): Acute Myeloid Leukemia (AML)
10
Active, not recruiting
Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia
Last Updated: January 12, 2012
Condition(s): Leukemia, Myelocytic, Acute
11
Recruiting
Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma
Last Updated: August 29, 2011
Condition(s): Multiple Myeloma
12
Recruiting
Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Children With Relapsed or Refractory High-Risk NBL.
Last Updated: January 18, 2011
Condition(s): Neuroblastoma
13
Recruiting
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Last Updated: March 10, 2011
Condition(s): Leukemia; Cancer
14
Completed
Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
Last Updated: February 22, 2011
Condition(s): Stem Cell Transplantation; Graft Vs Host Disease
15
Recruiting
Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Last Updated: November 21, 2011
Condition(s): Acute Myeloid Leukemia; Advanced Myelodysplastic Syndromes
16
Active, not recruiting
Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia
Last Updated: October 27, 2011
Condition(s): Acute Myeloid Leukemia
17
Not yet recruiting
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
Last Updated: September 23, 2011
Condition(s): Multiple Myeloma; Allogeneic Transplantation
18
Recruiting
Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Last Updated: May 18, 2012
Condition(s): Hodgkin's Disease
19
Active, not recruiting
Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission
Last Updated: April 25, 2012
Condition(s): Adult Acute Lymphoblastic Leukemia in Remission; Childhood Acute Lymphoblastic Leukemia in Remission; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia
20
Recruiting
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Last Updated: November 21, 2011
Condition(s): Aplastic Anemia; Leukemia; Myelodysplastic Syndrome

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=transplant+related+mortality

Page 1 of Clinical Trials for transplant related mortality, 448 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About